搜索结果



疾病ID:TCMBANKDI025977


疾病名:Bronchial Hyperreactivity


MeSH_Name:Respiratory Tract Diseases


HPO_Name:-


UMLS_Name:Disease or Syndrome


DO_Name:-


疾病类型:disease


DisGeNET_Link:C0085129


MeSH_Link:C08


HPO_Link:-


UMLS_Link:T047


DO_Link:-


HERB_ID:-


   疾病对应的植物
ID 拉丁名 药名 药用植物名 功能与主治 来源 药用部位 使用民族

   疾病对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN058906 imperatorin HY-N0285; I06-0320; 9-[(3-METHYL-2-BUTEN-1-YL)OXY]-7H-FURO[3,2-G][1]BENZOPYRAN-7-ONE; BDBM50308719; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(3-methyl-2-buten-1-yl)oxy]-; SpecPlus_000755; DSSTox_CID_28663; Imperatorin, European Pharmacopoeia (EP) Reference Standard; EINECS 207-581-1; ZB000436; KBio2_006371; SMR000156241; 9-[(3-Methyl-2-butenyl)oxy]-7H-furo[3,2-g]chromen-7-one #; AI3-61725; AC1L1UPZ; 9-(3-methylbut-2-enyloxy)furano[3,2-g]chromen-2-one; NCGC00095209-04; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-((3-methyl-2-butenyl)oxy)-; KBio1_001795; 9-(3-methylbut-2-enoxy)-7-furo[3,2-g][1]benzopyranone; 8-isopent-2-enyloxy-6,7-furanocoumarin; Marmelide; ACon1_001117; 6-Hydroxy-7-(3-methyl-2-butenyloxy)-5-benzofuranacrylic acid omega-lactone; (9-[(3-methyl-2-buten-1-yl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one); 9-[(3-Methyl-2-butenyl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one, 9CI; Pentasalen, BAN; AC-8046; 9-[(3-methylbut-2-en-1-yl)oxy]-7H-furo[3,2-g]chromen-7-one; 7H-Furo[3,2-g][1]benzopyran-7-one,9-[(3-methyl-2-buten-1-yl)oxy]-; Marmelosin; NCGC00095209-01; CAS-482-44-0; InChI=1/C16H14O4/c1-10(2)5-7-19-16-14-12(6-8-18-14)9-11-3-4-13(17)20-15(11)16/h3-6,8-9H,7H2,1-2H; 8-isopentenyloxypsoralen; Bio-0346; AN-8400; 5-Benzofuranacrylic acid, 6-hydroxy-7-((3-methyl-2-butenyl)oxy)-, delta-lactone; DivK1c_006851; 5-Benzofuranacrylic acid, 6-hydroxy-7-((3-methyl-2-butenyl)oxy)-, .delta.-lactone; CCG-38649; LS-70737; 9-(3-Methylbut-2-enyloxy)furo(3,2-g)chromen-7-one; ST45000841; HMS3354E04; SR-01000721772-2; 9-((3-methylbut-2-en-1-yl)oxy)-7H-furo[3,2-g]chromen-7-one; 9-(3-Methylbut-2-enyloxy)-7H-furo(3,2-g)chromen-7-one; KBio3_001050; 9-[(3-Methyl-2-butenyl)-oxy]-7H-furo[3,2-g][1][benzopyran-7-one; 9-[(3-methyl-2-butenyl)oxy]-7H-furo[3,2-g][1] benzopyran-7-one; NCGC00095209-06; Spectrum_000755; KBioGR_001864; HMS3261C08; Pentosalen; OLOOJGVNMBJLLR-UHFFFAOYSA-N; CTK5J8942; WLN: T C566 DO LVOTJ BO2UY1&1; C-16983; NCGC00095209-02; A827504; 9-[(3-methylbut-2-en-1-yl)oxy]-2H-furo[3,2-g]chromen-2-one; SPECTRUM102076; NSC402949; Imperatorin, >=98% (HPLC), powder; MEGxp0_000089; Marmelosin, analytical standard; NCGC00095209-03; FT-0603414; 9-[(3-Methylbut-2-enyl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one; imperatorin ; 7H-Furo[3, 9-[(3-methyl-2-butenyl)oxy]-; 8-(3-Methyl-2-butenyloxy)psoralen; KBioSS_001235; K713N25C78; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(3-methyl-2-butenyl)oxy]-; SDCCGMLS-0066373.P001; 9-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one; SCHEMBL50437; Tox21_500413; N1859; Spectrum2_000376; 9-[(3-methyl-2-buten-1-yl)oxy]-7H-furo[3,2-g]chromen-7-one; MFCD00016881; MLS000574838; KBio2_001235; LP00413; API0002987; 9-(3-Methyl-2-butenyloxy)-7-oxofuro[3,2-g]chromene; Pentosalen [BAN]; Ammidin; Spectrum5_000244; DTXSID8048737; DSSTox_GSID_48737; 8-Prenyloxypsoralen; HSDB 3497; BG01563273; 8-Isoamylenoxypsoralen; NSC 402949; CHEMBL453805; CC-29497; Enoxypsoralen; 5-hydroxy-8-(1,1-dimethylallyl)psoralen; NSC-402949; 8-Isopentenyloxypsoralene; 9-(3-Methylbut-2-enyloxy)furo[3,2-g]chromen-7-one; Q-100532; I0904; 9-((3-Methyl-2-butenyl)oxy)-7H-furo(3,2-g)(1)benzopyran-7-one; 482-44-0; DSSTox_RID_82933; UNII-K713N25C78; TR-036857; W1274; Tox21_113179; NCGC00169661-02; IMPERATORIN; ZINC1904; HMS2218G08; SR-01000721772; Tox21_113179_1; SPBio_000531; CS-5800; KBio2_003803; MCULE-3248623364; Spectrum3_000145; HMS1922N22; CCRIS 4346; C09269; SC-16643; NCGC00095209-05; 482I440; NCGC00261098-01; NCGC00169661-01; MolPort-000-881-264; Oprea1_407817; AKOS000277029; Spectrum4_001422; 9-[(3-methyl-2-butenyl)oxy]-7H-furo[3,2-g]-1-benzopyran-7-one; D09ROW; CHEBI:5885; CI0030; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-((3-methyl-2-butenyl)oxy)-; 70102-00-0; BSPBio_001850; AIDS071128; MLS000574838; ZINC00001904; 9-(3-Methylbut-2-enyloxy)-7H-furo(3,2-g)chromen-7-one; KBio3_001050; SpecPlus_000755; Spectrum_000755; KBioGR_001864; KBio2_001235; EINECS 207-581-1; Pentosalen; SPBio_000531; KBio2_006371; SMR000156241; WLN: T C566 DO LVOTJ BO2UY1&1; Spectrum5_000244; KBio2_003803; AI3-61725; Spectrum3_000145; NCGC00095209-02; 9-(3-methylbut-2-enoxy)-7-furo[3,2-g]chromenone; CCRIS 4346; Imperatorin; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-((3-methyl-2-butenyl)oxy)-; SPECTRUM102076; HSDB 3497; C09269; AIDS-071128; KBio1_001795; 8-Isoamylenoxypsoralen; NSC 402949; NSC402949; MEGxp0_000089; ACon1_001117; 6-Hydroxy-7-(3-methyl-2-butenyloxy)-5-benzofuranacrylic acid omega-lactone; 8-Isopentenyloxypsoralene; 9-(3-Methylbut-2-enyloxy)furo[3,2-g]chromen-7-one; 9-[(3-methylbut-2-en-1-yl)oxy]-7H-furo[3,2-g]chromen-7-one; KBioSS_001235; 9-((3-Methyl-2-butenyl)oxy)-7H-furo(3,2-g)(1)benzopyran-7-one; Oprea1_407817; 482-44-0; Spectrum4_001422; Marmelosin; NCGC00095209-01; SDCCGMLS-0066373.P001; InChI=1/C16H14O4/c1-10(2)5-7-19-16-14-12(6-8-18-14)9-11-3-4-13(17)20-15(11)16/h3-6,8-9H,7H2,1-2H; 9-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one; ST5308976; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(3-methyl-2-butenyl)oxy]-; 5-Benzofuranacrylic acid, 6-hydroxy-7-((3-methyl-2-butenyl)oxy)-, delta-lactone; 5-Benzofuranacrylic acid, 6-hydroxy-7-[(3-methyl-2-butenyl)oxy]-, .delta.-lactone; DivK1c_006851; Spectrum2_000376; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-((3-methyl-2-butenyl)oxy)-; 9-(3-Methylbut-2-enyloxy)furo(3,2-g)chromen-7-one; 70102-00-0; BSPBio_001850; HY-N0285; I06-0320; 9-[(3-METHYL-2-BUTEN-1-YL)OXY]-7H-FURO[3,2-G][1]BENZOPYRAN-7-ONE; BDBM50308719; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(3-methyl-2-buten-1-yl)oxy]-; SpecPlus_000755; DSSTox_CID_28663; Imperatorin, European Pharmacopoeia (EP) Reference Standard; EINECS 207-581-1; ZB000436; KBio2_006371; SMR000156241; 9-[(3-Methyl-2-butenyl)oxy]-7H-furo[3,2-g]chromen-7-one #; AI3-61725; AC1L1UPZ; 9-(3-methylbut-2-enyloxy)furano[3,2-g]chromen-2-one; NCGC00095209-04; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-((3-methyl-2-butenyl)oxy)-; KBio1_001795; 9-(3-methylbut-2-enoxy)-7-furo[3,2-g][1]benzopyranone; Marmelide; ACon1_001117; 6-Hydroxy-7-(3-methyl-2-butenyloxy)-5-benzofuranacrylic acid omega-lactone; (9-[(3-methyl-2-buten-1-yl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one); 9-[(3-Methyl-2-butenyl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one, 9CI; Pentasalen, BAN; AC-8046; 9-[(3-methylbut-2-en-1-yl)oxy]-7H-furo[3,2-g]chromen-7-one; 7H-Furo[3,2-g][1]benzopyran-7-one,9-[(3-methyl-2-buten-1-yl)oxy]-; Marmelosin; NCGC00095209-01; CAS-482-44-0; InChI=1/C16H14O4/c1-10(2)5-7-19-16-14-12(6-8-18-14)9-11-3-4-13(17)20-15(11)16/h3-6,8-9H,7H2,1-2H; 8-isopentenyloxypsoralen; Bio-0346; AN-8400; 5-Benzofuranacrylic acid, 6-hydroxy-7-((3-methyl-2-butenyl)oxy)-, delta-lactone; DivK1c_006851; 5-Benzofuranacrylic acid, 6-hydroxy-7-((3-methyl-2-butenyl)oxy)-, .delta.-lactone; CCG-38649; LS-70737; 9-(3-Methylbut-2-enyloxy)furo(3,2-g)chromen-7-one; ST45000841; HMS3354E04; SR-01000721772-2; 9-((3-methylbut-2-en-1-yl)oxy)-7H-furo[3,2-g]chromen-7-one; 9-(3-Methylbut-2-enyloxy)-7H-furo(3,2-g)chromen-7-one; KBio3_001050; 9-[(3-Methyl-2-butenyl)-oxy]-7H-furo[3,2-g][1][benzopyran-7-one; NCGC00095209-06; Spectrum_000755; KBioGR_001864; HMS3261C08; Pentosalen; OLOOJGVNMBJLLR-UHFFFAOYSA-N; CTK5J8942; WLN: T C566 DO LVOTJ BO2UY1&1; C-16983; NCGC00095209-02; A827504; 9-[(3-methylbut-2-en-1-yl)oxy]-2H-furo[3,2-g]chromen-2-one; SPECTRUM102076; NSC402949; Imperatorin, >=98% (HPLC), powder; MEGxp0_000089; Marmelosin, analytical standard; NCGC00095209-03; FT-0603414; 9-[(3-Methylbut-2-enyl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one; 7H-Furo[3, 9-[(3-methyl-2-butenyl)oxy]-; 8-(3-Methyl-2-butenyloxy)psoralen; KBioSS_001235; K713N25C78; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(3-methyl-2-butenyl)oxy]-; SDCCGMLS-0066373.P001; 9-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one; SCHEMBL50437; Tox21_500413; N1859; Spectrum2_000376; 9-[(3-methyl-2-buten-1-yl)oxy]-7H-furo[3,2-g]chromen-7-one; MFCD00016881; MLS000574838; KBio2_001235; LP00413; API0002987; 9-(3-Methyl-2-butenyloxy)-7-oxofuro[3,2-g]chromene; Pentosalen [BAN]; Ammidin; Spectrum5_000244; DTXSID8048737; DSSTox_GSID_48737; 8-Prenyloxypsoralen; HSDB 3497; BG01563273; 8-Isoamylenoxypsoralen; NSC 402949; CHEMBL453805; CC-29497; Enoxypsoralen; 5-hydroxy-8-(1,1-dimethylallyl)psoralen; NSC-402949; 8-Isopentenyloxypsoralene; 9-(3-Methylbut-2-enyloxy)furo[3,2-g]chromen-7-one; Q-100532; I0904; 9-((3-Methyl-2-butenyl)oxy)-7H-furo(3,2-g)(1)benzopyran-7-one; 482-44-0; DSSTox_RID_82933; UNII-K713N25C78; TR-036857; W1274; Tox21_113179; NCGC00169661-02; IMPERATORIN; ZINC1904; HMS2218G08; SR-01000721772; Tox21_113179_1; SPBio_000531; CS-5800; KBio2_003803; MCULE-3248623364; Spectrum3_000145; HMS1922N22; CCRIS 4346; C09269; SC-16643; NCGC00095209-05; 482I440; NCGC00261098-01; NCGC00169661-01; MolPort-000-881-264; Oprea1_407817; AKOS000277029; Spectrum4_001422; 9-[(3-methyl-2-butenyl)oxy]-7H-furo[3,2-g]-1-benzopyran-7-one; D09ROW; CHEBI:5885; CI0030; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-((3-methyl-2-butenyl)oxy)-; 70102-00-0; BSPBio_001850; Ammidin; imperatorine C16H14O4 270.28 g/mol CC(=CCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2)C

   疾病对应的靶点
靶点ID 基因名 基因别名 描述
TCMBANKGE000250 CCL5 D17S136E; RANTES; SCYA5; SIS-delta; SISd; TCP228; eoCP C-C motif chemokine ligand 5
TCMBANKGE000070 CAV1 BSCL3; CGL3; LCCNS; MSTP085; PPH3; VIP21 caveolin 1
TCMBANKGE001068 CXCL1 FSP; GRO1; GROa; MGSA; MGSA-a; NAP-3; SCYB1 C-X-C motif chemokine ligand 1
TCMBANKGE000452 CFTR ABC35; ABCC7; CF; CFTR/MRP; MRP7; TNR-CFTR; dJ760C5.1 CF transmembrane conductance regulator
TCMBANKGE014158 VIP PHM27 vasoactive intestinal peptide
TCMBANKGE011194 DPP10 DPL2; DPPY; DPRP-3; DPRP3 dipeptidyl peptidase like 10
TCMBANKGE003095 F2RL1 GPR11; PAR2 F2R like trypsin receptor 1
TCMBANKGE010692 KAT5 ESA1; HTATIP; HTATIP1; PLIP; TIP; TIP60; ZC2HC5; cPLA2 lysine acetyltransferase 5
TCMBANKGE000752 Il33 9230117N10Rik; Il-33; Il1f11; NF-HEV interleukin 33
TCMBANKGE004616 RBM45 DRB1; RB-1 RNA binding motif protein 45
TCMBANKGE001076 SOD2 GClnc1; IPO-B; IPOB; MNSOD; MVCD6; Mn-SOD superoxide dismutase 2
TCMBANKGE000316 IL5 EDF; IL-5; TRF interleukin 5
TCMBANKGE000861 PTGER4 EP4; EP4R prostaglandin E receptor 4
TCMBANKGE003847 PTTG1IP C21orf1; C21orf3; PBF PTTG1 interacting protein
TCMBANKGE000903 PTGS1 COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS prostaglandin-endoperoxide synthase 1
TCMBANKGE001052 NLRP3 AGTAVPRL; AII; AVP; C1orf7; CIAS1; CLR1.1; DFNA34; FCAS; FCAS1; FCU; KEFH; MWS; NALP3; PYPAF1 NLR family pyrin domain containing 3
TCMBANKGE012197 PTGDR AS1; ASRT1; DP; DP1; PTGDR1 prostaglandin D2 receptor
TCMBANKGE000274 CCL2 GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF C-C motif chemokine ligand 2
TCMBANKGE000241 CASP8 ALPS2B; CAP4; Casp-8; FLICE; MACH; MCH5 caspase 8
TCMBANKGE009024 SLC52A1 GPCR42; GPR172B; PAR2; RBFVD; RFT1; RFVT1; hRFT1; huPAR-2 solute carrier family 52 member 1
TCMBANKGE000190 SMPD1 ASM; ASMASE; NPD sphingomyelin phosphodiesterase 1
TCMBANKGE008888 CHI3L1 ASRT7; CGP-39; GP-39; GP39; HC-gp39; HCGP-3P; YK-40; YKL-40; YKL40; YYL-40; hCGP-39 chitinase 3 like 1
TCMBANKGE000205 NOS2 HEP-NOS; INOS; NOS; NOS2A nitric oxide synthase 2
TCMBANKGE006891 SLCO6A1 CT48; GST; OATP-I; OATP6A1; OATPY solute carrier organic anion transporter family member 6A1
TCMBANKGE000633 ADRB2 ADRB2R; ADRBR; B2AR; BAR; BETA2AR adrenoceptor beta 2
TCMBANKGE005686 CYSLTR1 CYSLT1; CYSLT1R; CYSLTR; HMTMF81 cysteinyl leukotriene receptor 1
TCMBANKGE000201 ESR1 ER; ESR; ESRA; ESTRR; Era; NR3A1 estrogen receptor 1
TCMBANKGE000882 SERPINE1 PAI; PAI-1; PAI1; PLANH1 serpin family E member 1
TCMBANKGE014381 PTGDR2 CD294; CRTH2; DL1R; DP2; GPR44 prostaglandin D2 receptor 2
TCMBANKGE000314 LTC4S - leukotriene C4 synthase
TCMBANKGE006352 PROC APC; PC; PROC1; THPH3; THPH4 protein C, inactivator of coagulation factors Va and VIIIa
TCMBANKGE000331 CALCA CALC1; CGRP; CGRP-I; CGRP-alpha; CGRP1; CT; KC; PCT calcitonin related polypeptide alpha
TCMBANKGE014710 GSDMB GSDMB-1; GSDML; PP4052; PRO2521 gasdermin B
TCMBANKGE000154 CCR2 CC-CKR-2; CCR-2; CCR2A; CCR2B; CD192; CKR2; CKR2A; CKR2B; CMKBR2; MCP-1-R C-C motif chemokine receptor 2
TCMBANKGE013582 SOD3 EC-SOD superoxide dismutase 3
TCMBANKGE000867 ITGB3 BDPLT16; BDPLT2; CD61; GP3A; GPIIIa; GT integrin subunit beta 3
TCMBANKGE000204 CXCL8 GCP-1; GCP1; IL8; LECT; LUCT; LYNAP; MDNCF; MONAP; NAF; NAP-1; NAP1; SCYB8 C-X-C motif chemokine ligand 8
TCMBANKGE011874 PHF11 APY; BCAP; IGEL; IGER; IGHER; NY-REN-34; NYREN34 PHD finger protein 11
TCMBANKGE000199 ICAM1 BB2; CD54; P3.58 intercellular adhesion molecule 1
TCMBANKGE003415 GATA3 HDR; HDRS GATA binding protein 3
TCMBANKGE015151 HPGDS GSTS; GSTS1; GSTS1-1; PGD2; PGDS hematopoietic prostaglandin D synthase
TCMBANKGE007025 ORMDL3 - ORMDL sphingolipid biosynthesis regulator 3
TCMBANKGE002036 CLDN18 SFTA5; SFTPJ claudin 18
TCMBANKGE001398 CASP10 ALPS2; FLICE2; MCH4 caspase 10
TCMBANKGE007368 GSTP1 DFN7; FAEES3; GST3; GSTP; HEL-S-22; PI glutathione S-transferase pi 1
TCMBANKGE006943 CHRM3 EGBRS; HM3; PBS cholinergic receptor muscarinic 3
TCMBANKGE001101 CCL3 G0S19-1; LD78ALPHA; MIP-1-alpha; MIP1A; SCYA3 C-C motif chemokine ligand 3
TCMBANKGE012997 FEV HSRNAFEV; PET-1 FEV transcription factor, ETS family member
TCMBANKGE001007 NR1I2 BXR; ONR1; PAR; PAR1; PAR2; PARq; PRR; PXR; SAR; SXR nuclear receptor subfamily 1 group I member 2
TCMBANKGE001190 TACR1 NK1R; NKIR; SPR; TAC1R tachykinin receptor 1
TCMBANKGE001697 MMP1 CLG; CLGN matrix metallopeptidase 1
TCMBANKGE004539 HNMT HMT; HNMT-S1; HNMT-S2; MRT51 histamine N-methyltransferase
TCMBANKGE009985 P2RX4 P2X4; P2X4R purinergic receptor P2X 4
TCMBANKGE000428 SERPINA1 A1A; A1AT; AAT; PI; PI1; PRO2275; alpha1AT; nNIF serpin family A member 1
TCMBANKGE002087 ADAM33 C20orf153; DJ964F7.1 ADAM metallopeptidase domain 33
TCMBANKGE000041 IRF1 IRF-1; MAR interferon regulatory factor 1
TCMBANKGE009008 F11R CD321; JAM; JAM1; JAMA; JCAM; KAT; PAM-1 F11 receptor
TCMBANKGE004786 SCGB1A1 CC10; CC16; CCPBP; CCSP; UGB; UP-1; UP1 secretoglobin family 1A member 1
TCMBANKGE002000 CTLA4 ALPS5; CD; CD152; CELIAC3; CTLA-4; GRD4; GSE; IDDM12 cytotoxic T-lymphocyte associated protein 4
TCMBANKGE011342 NGF Beta-NGF; HSAN5; NGFB nerve growth factor
TCMBANKGE002516 GSTK1 GST; GST 13-13; GST13; GST13-13; GSTK1-1; hGSTK1 glutathione S-transferase kappa 1
TCMBANKGE001144 CD14 - CD14 molecule
TCMBANKGE009742 HLA-DRB1 DRB1; HLA-DR1B; HLA-DRB; SS1 major histocompatibility complex, class II, DR beta 1
TCMBANKGE009543 LTA LT; TNFB; TNFSF1; TNLG1E lymphotoxin alpha
TCMBANKGE013356 IL4R CD124; IL-4RA; IL4RA interleukin 4 receptor
TCMBANKGE002550 NPSR1 ASRT2; GPR154; GPRA; NPSR; PGR14; VRR1 neuropeptide S receptor 1
TCMBANKGE001860 IGHE IgE immunoglobulin heavy constant epsilon
TCMBANKGE003577 PLA2G4A GURDP; PLA2G4; cPLA2; cPLA2-alpha phospholipase A2 group IVA
TCMBANKGE002058 UQCRC2 MC3DN5; QCR2; UQCR2 ubiquinol-cytochrome c reductase core protein 2
TCMBANKGE004079 NDUFA2 B8; CD14; CIB8; MC1DN13 NADH:ubiquinone oxidoreductase subunit A2
TCMBANKGE006248 FCER2 BLAST-2; CD23; CD23A; CLEC4J; FCE2; IGEBF Fc fragment of IgE receptor II
TCMBANKGE001096 TLR4 ARMD10; CD284; TLR-4; TOLL toll like receptor 4
TCMBANKGE004236 RNASE3 ECP; RAF1; RNS3 ribonuclease A family member 3
TCMBANKGE000778 TAC1 Hs.2563; NK2; NKNA; NPK; TAC2 tachykinin precursor 1
TCMBANKGE007886 HLA-G MHC-G major histocompatibility complex, class I, G
TCMBANKGE002395 HLA-DOA HLA-DNA; HLA-DZA; HLADZ major histocompatibility complex, class II, DO alpha
TCMBANKGE012224 VDR NR1I1; PPP1R163 vitamin D receptor
TCMBANKGE010614 SFTPD COLEC7; PSP-D; SFTP4; SP-D surfactant protein D
TCMBANKGE001085 MAPK8 JNK; JNK-46; JNK1; JNK1A2; JNK21B1/2; PRKM8; SAPK1; SAPK1c mitogen-activated protein kinase 8
TCMBANKGE000421 IL9 HP40; IL-9; P40 interleukin 9
TCMBANKGE006822 HHIP HIP hedgehog interacting protein
TCMBANKGE000703 AREG AR; AREGB; CRDGF; SDGF amphiregulin
TCMBANKGE000498 TBX21 T-PET; T-bet; TBET; TBLYM T-box transcription factor 21
TCMBANKGE000408 CCR3 C C CKR3; CC-CKR-3; CD193; CKR 3; CKR3; CMKBR3 C-C motif chemokine receptor 3
TCMBANKGE000764 TRPV1 VR1 transient receptor potential cation channel subfamily V member 1
TCMBANKGE001029 IL13 IL-13; P600 interleukin 13
TCMBANKGE000075 IL1RN DIRA; ICIL-1RA; IL-1RN; IL-1ra; IL-1ra3; IL1F3; IL1RA; IRAP; MVCD4 interleukin 1 receptor antagonist
TCMBANKGE003305 HBEGF DTR; DTS; DTSF; HEGFL heparin binding EGF like growth factor
TCMBANKGE000315 IL4 BCGF-1; BCGF1; BSF-1; BSF1; IL-4 interleukin 4
TCMBANKGE000252 PDE4A DPDE2; PDE4; PDE46 phosphodiesterase 4A
TCMBANKGE011186 CHRNA3 BAIPRCK; LNCR2; NACHRA3; PAOD2 cholinergic receptor nicotinic alpha 3 subunit
TCMBANKGE000819 TRPA1 ANKTM1; FEPS; FEPS1 transient receptor potential cation channel subfamily A member 1